These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33618970)

  • 21. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions.
    Ball JG; Hollin IL
    Res Social Adm Pharm; 2022 Aug; 18(8):3402-3413. PubMed ID: 34819265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in exposure to televised prescription drug advertising, 2003-2011.
    Kornfield R; Alexander GC; Qato DM; Kim Y; Hirsch JD; Emery SL
    Am J Prev Med; 2015 May; 48(5):575-9. PubMed ID: 25891057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription.
    Fogel J; Zhuk A
    Health Mark Q; 2019; 36(3):220-235. PubMed ID: 31267822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising.
    Sullivan HW; O'Donoghue AC; Boudewyns V; Paquin RS; Ferriola-Bruckenstein K
    Oncologist; 2023 Jul; 28(7):e542-e553. PubMed ID: 37079495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
    Ju I; Ohs JE; Park JS
    Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.
    O'Donoghue AC; Johnson M; Sullivan HW; Parvanta S; Ray S; Southwell BG
    J Health Commun; 2019; 24(4):368-376. PubMed ID: 31012394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thinking outside the medicine cabinet: a comparative content analysis of direct-to-consumer advertisements for prescription drug treatments.
    McKeever R
    Health Mark Q; 2014; 31(4):353-69. PubMed ID: 25405635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K; Kim J; Ross JS
    J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
    Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
    Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements.
    Fahim G; Toscani M; Barone JA; Wang C; Gandhi S
    Ther Innov Regul Sci; 2018 Jan; 52(1):114-117. PubMed ID: 29714616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.
    Grenard JL; Uy V; Pagán JA; Frosch DL
    Patient Educ Couns; 2011 Oct; 85(1):79-84. PubMed ID: 21044826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is exposure to pharmaceutical direct-to-consumer advertising for heart disease and diabetes associated with physical activity and dietary behavior?
    Niederdeppe J; Avery RJ; Liu J; Mann C; Sood N; Eisenberg MD
    Soc Sci Med; 2023 Aug; 330():116062. PubMed ID: 37418992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Narratives to Deliver Information in Direct-To-Consumer Prescription Drug Commercials: A Content Analysis.
    Ball JG; Applequist J
    J Health Commun; 2019; 24(5):512-524. PubMed ID: 31256712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Messages in prescription drug advertising for four chronic diseases, 2003-2016: A content analysis.
    Avery RJ; Niederdeppe J; Eisenberg MD; Sood N; Welch B; Kim JJ
    Prev Med; 2022 May; 158():107015. PubMed ID: 35248679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A content analysis of direct-to-consumer television prescription drug advertisements.
    Kaphingst KA; DeJong W; Rudd RE; Daltroy LH
    J Health Commun; 2004; 9(6):515-28. PubMed ID: 15764450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
    Sumpradit N; Ascione FJ; Bagozzi RP
    Clin Ther; 2004 Jan; 26(1):135-54. PubMed ID: 14996526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of imagination in consumers' processing of visual metaphors in prescription drug advertising.
    Foreman JR; Hsieh MH; Grover A
    Health Mark Q; 2019; 36(3):169-185. PubMed ID: 31180277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.